WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

WuXi Biologics Launches an Integrated Biologics CRDMO Center in Fengxian, Shanghai https://www.prnewswire.com/news-releases/wuxi-biologics-launches-an-integrated-biologics-crdmo-center-in-fengxian-shanghai-301683701.html

"Research Report" Morgan Stanley lists the list of stocks benefiting from China's "re-clearance" theme http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1226228/3 Morgan Stanley released the 2023 China Capital Market Strategy Report, stating that it listed a list of stocks that benefited from China's "reopening" theme: Stocks to see: ... WUXI BIO ...

Ja das stimmt... politisch ist es heikel

Mit dem Wert habe ich eigentlich kein Problem, aber die Politik macht es gerade nicht so leicht.

Hab heute nachgekauft

WuXi Biologics Provides Corporate Updates https://www.prnewswire.com/news-releases/wuxi-biologics-provides-corporate-updates-301661384.html

https://www.prnewswire.com/news-releases/wuxi-biologics-announces-gmp-release-of-48-000l-commercial-drug-substance-manufacturing-facility-in-hebei-china-301659418.html

WUXI BIO Buys back 4M Shrs for $156M http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1221334/company-news/HK6

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1221086/company-news/HK6 WUXI BIO Buys back 5M Shrs for $213M Last Fri

https://m.hkej.com/landing/mobarticle2?id=3279793 The list of the new Standing Committee of the Political Bureau of the Central Committee of the Communist Party of China has been announced, and the central economic decision-making team is expected to be restructured. The market is concerned about the impact on the Greater China stock market.  ...

WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities https://www.prnewswire.com/news-releases/wuxi-biologics-released-a-new-cgmp-drug-product-manufacturing-facility-to-support-end-to-end-services-for-diversified-modalities-301656720.html • WuXi Biologics adds further capacity and capability for drug product fill & finish, providing global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP

Sie kaufen ja immer günstiger zurück 😉 ich hoffe, dass hier bald Mal etwas Stabilität zurückkehrt.

WuXi Biologics (02269 HK) repurchased 5 million shares with a capital of 236 million yuan https://hk.news.yahoo.com/%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9-02269-hk-%E5%9B%9E%E8%B3%BC500%E8%90%AC%E8%82%A1-%E6%B6%89%E8%B3%872-201843656.html

WuXi Biologics (02269 HK) repurchased 3.2 million shares yesterday, involving nearly 160 million yuan http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1220037/2

WuXi Biologics (02269 HK) repurchased 5 million shares yesterday, involving 236 million http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1219105/3

WuXi Biologics Receives "Best CDMO Award of the Year" https://www.prnewswire.com/news-releases/wuxi-biologics-receives-best-cdmo-award-of-the-year-301648370.html ...The winners were determined through voting by more than 200 biopharma companies and service providers involved in biologics manufacturing in the APAC regions. ...